CFGS
TXMD icon

Concourse Financial Group Securities’s TherapeuticsMD TXMD Stock Holding History

Concourse Financial Group Securities’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-20
Closed -$2.82K – 2139
2019
Q2 		$3K Hold
20
– – ﹤0.01% 1929
2019
Q1 		$4K Hold
20
– – ﹤0.01% 1856
2018
Q4 		$3K Buy
+20
New +$4.88K ﹤0.01% 1857

Other funds holding TXMD

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Concourse Financial Group Securities's TXMD Position: Q3 2019 in Review

Concourse Financial Group Securities sold out of TherapeuticsMD (TXMD) in Q3 2019, closing a stake of 20 shares — an estimated $2.82K sold.

Concourse Financial Group Securities first reported a position in TXMD in Q4 2018 and held it in 3 quarters. The position peaked at $4K in Q1 2019. 150 funds tracked by Wall St. Rank hold TXMD as of Q3 2019.

  • Concourse Financial Group Securities reported no remaining TherapeuticsMD position as of Q3 2019 after selling out during the quarter.
  • Concourse Financial Group Securities sold 20 TherapeuticsMD shares in Q3 2019, an estimated $2.82K.
  • Concourse Financial Group Securities first reported a position in TherapeuticsMD in Q4 2018 and held it in 3 quarters.
  • Concourse Financial Group Securities's TherapeuticsMD position peaked at $4K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2019.

Based on Concourse Financial Group Securities's 13F filing for Q3 2019, filed 13 Nov 2019.